London Stock Exchange Group Plc's planned purchase of Refinitiv in a $27 billion deal is the latest sign that exchange operators are focusing more on data products to increase revenue, while also trying to expand their global reach.
Saudi Basic Industries Corp (SABIC) has no interest in taking over Swiss chemicals firm Clariant and considers its 25% stake in the company as "a long term strategic investment," said its chief executive Yousef al-Benyan on Sunday.
Real estate and utilities are the two sectors that have benefited the most from the rise of passive investing vehicles.
Even as college costs soar, these well-regarded schools charge no tuition at all.
Hidden or unexpected fees on everything from concert tickets to hotel stays are costly. Here's what you can do to avoid the annoying surprise.
There are pros and cons to dual enrollment and AP courses.
U.S. buyout fund Blackstone Group Inc is expected to announce the merger of its majority-owned financial data firm Refinitiv with the London Stock Exchange Group Plc within a week, but the deal is expected to face a long antitrust review before it can close, four sources told Reuters.
BlackRock Inc , an investor in Cofense Inc, is in advanced talks to take over the U.S. cyber security firm, after a U.S. national security panel asked buyout firm Pamplona Capital Management LLP to sell its stake, people familiar with the matter said on Sunday.
U.S. and Chinese trade negotiators shift to Shanghai this week for their first in-person talks since a G20 truce last month, a change of scenery for two sides struggling to resolve deep differences on how to end a year-long trade war.
Two years ago, Satish P., a bakery owner in the small village of Harohalli near Bengaluru, had his doubts about stocking Mondelez's Cadbury Silk bars.
Asian shares got off to a cautious start on Monday as markets count down to a likely cut in U.S. interest rates this week with much riding on whether or not the Federal Reserve signals yet more are in the pipeline.
Asian shares drifted lower on Monday as markets anxiously counted down to a likely cut in U.S. interest rates this week with much riding on whether or not the Federal Reserve signals yet more are in the pipeline.
Novartis Chief Executive Vas Narasimhan pledged in an interview published on Saturday not to sell the Swiss drugmaker's generics unit Sandoz amid a revamp that has prompted speculation he is preparing to offload the business.
Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.
Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, according to a source familiar with the matter.